Mouse, Human 交差が予測される動物種:
Rat, Rabbit, Chicken, Chimpanzee, Macaque monkey, Gorilla, Chinese hamster, Orangutan
Synthetic peptide corresponding to Human TrkB aa 500-600 conjugated to keyhole limpet haemocyanin. The peptide is phosphorylated at Y515 (Peptide available as ab135233)
This antibody gave a positive signal in both Human Brain and Human Spinal Cord tissue lysates.
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C or -80°C. Avoid freeze / thaw cycle.
pH: 7.40 Preservative: 0.02% Sodium azide Constituent: PBS Note: Batches of this product that have a concentration < 1mg/ml may have BSA added as a stabilising agent. If you would like information about the formulation of a specific lot, please contact our scientific support team who will be happy to help.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Use at an assay dependent concentration.
Use a concentration of 1 µg/ml. Detects a band of approximately 85 kDa (predicted molecular weight: 91 kDa).
Receptor for brain-derived neurotrophic factor (BDNF), neurotrophin-3 and neurotrophin-4/5 but not nerve growth factor (NGF). Involved in the development and/or maintenance of the nervous system. This is a tyrosine-protein kinase receptor. Known substrates for the TRK receptors are SHC1, PI-3 kinase, and PLC-gamma-1.
Isoform TrkB is widely expressed, mainly in the nervous tissue. In the CNS, expression is observed in the cerebral cortex, hippocampus, thalamus, choroid plexus, granular layer of the cerebellum, brain stem, and spinal cord. In the peripheral nervous system, it is expressed in many cranial ganglia, the ophtalmic nerve, the vestibular system, multiple facial structures, the submaxillary glands, and dorsal root ganglia. Isoform TrkB-T1 is expressed in multiple tissues, mainly in brain, pancreas, kidney and heart. Isoform TrkB-T-Shc is predominantly expressed in brain.
Belongs to the protein kinase superfamily. Tyr protein kinase family. Insulin receptor subfamily. Contains 2 Ig-like C2-type (immunoglobulin-like) domains. Contains 2 LRR (leucine-rich) repeats. Contains 1 LRRCT domain. Contains 1 LRRNT domain. Contains 1 protein kinase domain.
Neurotrophic tyrosine kinase receptor type 2 antibody
Neurotrophin receptor tyrosine kinase type 2 antibody
NTRK 2 antibody
Obesity, hyperphagia, and developmental delay, included antibody
Trk B antibody
TrkB tyrosine kinase antibody
Tropomyosin related kinase B antibody
tyrosine kinase receptor B antibody
Tyrosine receptor kinase B antibody
Western blot - Anti-TrkB (phospho Y515) antibody (ab109684)
All lanes : Anti-TrkB (phospho Y515) antibody (ab109684) at 1 µg/ml
Lane 1 : Human brain tissue lysate - total protein (ab29466) Lane 2 : Human spinal cord tissue lysate - total protein (ab29188) Lane 3 : Human brain tissue lysate - total protein (ab29466) with Immunizing peptide at 1 µg/ml Lane 4 : Human spinal cord tissue lysate - total protein (ab29188) with Immunizing peptide at 1 µg/ml Lane 5 : Human brain tissue lysate - total protein (ab29466) with Control peptide at 1 µg/ml Lane 6 : Human spinal cord tissue lysate - total protein (ab29188) with Control peptide at 1 µg/ml
Lysates/proteins at 10 µg per lane.
Secondary All lanes : Goat Anti-Rabbit IgG H&L (HRP) preadsorbed (ab97080) at 1/5000 dilution
ab109684 was tested using an Indirect ELISA approach. The wells were coated with peptide (1µg/ml at 100µl/well) overnight at 4°C, followed by a 5% BSA blocking step for 1 hour at room temperature. The primary Ab was then added at a dilution range of 1- 0.00025µg/ml (100µl/well) for 1hr at room temperature. A HRP-conjugated anti-rabbit IgG (heavy and light chain) was used as a secondary antibody at 1:20,000 dilution for 1hr at room temperature.
Chang LH et al. Blockade of soluble epoxide hydrolase attenuates post-ischemic neuronal hyperexcitation and confers resilience against stroke with TrkB activation. Sci Rep8:118 (2018).
Read more (PubMed: 29311641) »
Ullrich M et al. OCD-like behavior is caused by dysfunction of thalamo-amygdala circuits and upregulated TrkB/ERK-MAPK signaling as a result of SPRED2 deficiency. Mol PsychiatryN/A:N/A (2017).
Read more (PubMed: 28070119) »